Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 8,572 shares at $63.69 ($546K) on 2024-01-23, disclosed to the SEC on 2024-01-24.
Scheduled sale ($546k) by Chief People Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.69 | 4,286 | $273K | 50.0% |
| 2 | $63.69 | 4,286 | $273K | 50.0% |
| Total | $63.69 avg | 8,572 | $546K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $37K | — | Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-31 | $139K | — | Filing → |